longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Pomdoctor

POM

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.13, above the reasonable range, cheaper than 0% of the time in the past 1 years, and the industry ranks 6/14, the industry Median -0.14.

-0.129xP/E
$0.92Stock price
$-7.14Earnings per share
-0.129xP/E
Stock price$0.92Earnings per share$-7.14

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-1.43x
Typical range
-3.03x–-0.26x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
08162432

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x10x20x30x40x50x
P/E ratio
Name/Symbol
AHCOUSAdaptHealth
-3.40x145.14%$774.44M
AHGUSAkso Health
-30.15x--$562.90M
ACHUSAccendra Health
-0.14x89.03%$42.90M
COSMUSCosmos Health
-1.59x66.67%$38.85M
MEDSUSDataMeds AI
-0.14x--$12.43M
ZSTKUSZeroStack
-0.07x90.76%$11.77M
POMUSPomdoctor
-0.13x--$6.86M
ATPCUSAgape ATP
-1.78x--$2.02M
VRAXUSVirax Biolabs
-0.36x52.53%$1.79M
BIMIUSBIMI International Medical
----$2.79K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.